Crystal forms of atorvastatin

Archives of Pharmacal Research

Volumn 32, Issue 6, 2009, Pages 933-936

  An, Su Gyeong ^a   Sohn, Young Taek ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Atorvastatin; Crystal form; DSC; Polymorphism; Pseudopolymorphism; PXRD; TG; Transformation

Indexed keywords

ATORVASTATIN;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; STRUCTURE ANALYSIS;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; HEPTANOIC ACIDS; PYRROLES; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 68149165732     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-009-1616-0     Document Type: Article

References (14)

1. 13C nuclear magnetic resonance relaxation time obtained from the heating rate dependence of the glass transition temperature J. Pharm. Sci. 90 798 806 (Pubitemid 32536774)
2. A. Bauer-Brandl Y. T. Sohn 1994 Crystal modifications of cimetidine: characterization and evaluation for manufacturing of dosage forms Eur. J. Pharm. Biopharm. 40 Suppl. 6S
3. A. Burger K. Schulte R. Ramberger 1980 Aufklaerung thermodynamischer Beziehungen zwischen fuenf polymorphen Modifikationen von Sulfapyridin mittel DSC J. Therm. Anal. Cal. 19 475 484
4. A. Grünenberg 1997 Polymorphie und thermische Analyse pharmazeutischer Wirkstoffe Pharmazie in unserer Zeit 26 224 231 (Pubitemid 27514542)
5. J. K. Haleblian 1975 Characterization of habits and crystalline modification of solids and their pharmaceutical applications J. Pharm. Sci. 64 1269 1288
6. J. K. Haleblian W. C. McCrone 1969 Pharmaceutical applications of polymorphism J. Pharm. Sci. 58 911 929
7. W. I. Higuchi P. K. Lau T. Higuchi J. W. Shell 1963 Polymorphism and drug availability, solubility relations in the methylprednisolone system J. Pharm. Sci. 52 150 153
8. R. Hüttenrauch 1988 Fundamentals of Pharmaceutics Acta Pharm. Technol. 34 1 10
9. M. Kuhnert-Brandstätter H. Winkler 1976 Thermoanalytische und IR-spektroskopische Untersuchungen an verschiedenen Kristallformen von Arzneistoffen aus der Oestradiol- und Androstangruppe Sci. Pharm. 44 288 299
10. E. A. Lee Y. T. Sohn 2008 Crystal forms of a capsaicin derivative analgesic DA-5018 J. Therm. Anal. Cal. 93 871 874
11. J. W. Shell 1963 X-ray and crystallographic applications in pharmaceutical research III. Crystal habit quantitation J. Pharm. Sci. 52 100 101
12. Y. T. Sohn 2004 Effect of crystal form on bioavailability J. Kor. Pharm. Sci. 34 443 452
13. Y. T. Sohn 2007 Crystal forms of an angiotensin II receptor antagonist BR-A657 J. Therm. Anal. Cal. 89 799 802 (Pubitemid 47351774)
14. Y. T. Sohn Y. H. Lee 2005 Polymorphism of doxazosin mesylate Arch. Pharm. Res. 28 730 735